Depo Testosterone Treatment Lawsuit Alleges Increase In Heart Problems Due to Taking Testosterone Injections; Wright & Schulte LLC Reports

Print

A Recent Depo Testosterone Treatment Lawsuit Claims Pfizer Inc. Downplayed Serious Cardiac Side Effects Allegedly Associated With The Use Of Testosterone Medication

depo-testosterone-treatment-lawsuit-wright-and-schulte-llcWright & Schulte LLC has learned that a Depo testosterone treatment lawsuit has been filed on behalf of a Lafayette, Louisiana, man who suffered an elevated heart rate and an increase in hypertension, that was “mild” prior to taking the testosterone injections. The Louisiana man began taking Depo testosterone injections in 2012 when he was 41 and continued until 2014. This Depo testosterone lawsuit, filed on May 28, 2014 in the U.S. District Court, Western District of Louisiana (Case No. 6:14-cv-01050), alleges the Louisiana man was prescribed the Depo injections to treat hypogonadism or a “low testosterone” condition and as a result he has suffered life-threatening cardiac side-effects purportedly due to the testosterone treatment drug.

The Depo lawsuit contends that the defendants, Pfizer Inc, which manufactures Depo Testosterone, and Pharmacia & Upjohn which distributes the product, deceived potential users by relaying positive information about Depo Testosterone, and downplayed known adverse and serious health effects from taking testosterone injections, which include cardiovascular disease, strokes, and myocardial infarctions (heart attacks).

In January 2014, the U.S. Food & Drug Administration (FDA) announced its plans to reassess the safety of all FDA-approved testosterone replacement therapy products, including Depo Testosterone, because of studies showing the risk of heart attacks, strokes and death in men using the medication. One study published in the November 2013 Journal of the American Medical Association, found that older men who had an underlying cardiovascular disease and took prescription testosterone treatment medication had a 30 percent increased risk of having a stroke, heart attack, or death, over the men who did not take testosterone medication. A second research article, published January 29, 2014 in the PLOS One Journal, found that men 65 years and older along with younger men with pre-existing heart disease who took prescribed testosterone medication, had a higher risk of having a heart attack within the first 90 days after taking the first prescription.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]

The men represented in these AndroGel, Androderm, and Testim lawsuits alleged taking prescribed testosterone caused them to suffered strokes, heart attacks, and potentially deadly cardiovascular problems, including heart attack, stroke, and blood clots. In March 2014, with the amount of testosterone lawsuits rising to above 80, plaintiffs filed motions to consolidate all testosterone lawsuits across the country. (In Re: AndroGel Product Liability Litigation, MDL Docket No. 36) and (In Re: Testosterone Products Liability Litigation, No. 42, JPML)

According to court records, this Depo Lawsuit joins the more than 80 testosterone lawsuits involving AndroGel, Testim, Androderm and other low testosterone therapy medications that were recently consolidated into an industry-wide MDL (2545). The men represented in these AndroGel, Androderm, and Testim lawsuits alleged taking testosterone medications caused them to suffered strokes, heart attacks, and other potentially deadly cardiac issues. (In Re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

According to court records, Pfizer and Pharmacia & Upjohn opposed the recent consolidation and asked the JPML in April 2014 to exclude all Depo testosterone lawsuits since the injection therapy was only named in four lawsuits. According to Pfizer’s motion, other lawsuits involving testosterone topical gel products like AndroGel, Fortesta and Testim, were different than complaints involving Depo Testosterone. The JPML acknowledged in its Transfer Order the testosterone companies’ concerns but noted that all the testosterone replacement lawsuits contain common questions of fact and centralizing the complaints will be more convenient for all parties involved. (In Re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Wright & Schulte LLC is offering a free legal consultation for men who used Depo Testosterone or another testosterone drug and experienced severe and life-threatening side effects during the treatment. To learn more about filing a low testosterone therapy lawsuit, contact the defective drug attorneys at Wright & Schulte by visiting yourlegahelp.com

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free testosterone lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.